 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GU - Pancriatic Cancer Trials in St. Louis, MO
A Phase III Trial Evaluating Both
Erlotinib and Chemoradiation as Adjuvant Treatment for
Patients with Resected Head of Pancreas Adenocarcinoma
(Erlotinib Provided)
RTOG 0848
(MBMC Contact: Henry
Robinson 314-996-5865)
Click
For Consent
***
(RTOG Credentialing Required for Affiliate Sites Prior to Patient
Registration - See Protocol)
***Available
through CTSU
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|